首页> 外文期刊>Polimeri >Effective anti-adhesives of uropathogenic Escherichia coli
【24h】

Effective anti-adhesives of uropathogenic Escherichia coli

机译:尿路致病性大肠杆菌的有效抗粘连剂

获取原文
       

摘要

Urinary tract infections (UTIs) caused by uropathogenic Escherichia coli (UPEC) are among the most common infectious diseases in humans. Due to their frequent occurrence in the community and nosocomial settings, as well as the development of resistance to the commonly prescribed antimicrobial agents, an enormous financial burden is placed on healthcare systems around the world. Therefore, novel approaches to the prevention and treatment of UTIs are needed. Although UPEC may harbour a plethora of virulence factors, type I fimbriae and P pili are two of the most studied adhesive organelles, since the attachment to host cells in the urinary tract is a crucial step towards infection. Design of receptor analogues that competitively bind to UPEC surface adhesins placed at the top of pili organelles led to the development of anti-adhesive drugs that are increasingly recognized as important and promising alternatives to antibiotic treatment of UTIs
机译:由尿路致病性大肠杆菌(UPEC)引起的尿路感染(UTI)是人类最常见的传染病之一。由于它们在社区和医院环境中的频繁发生,以及对常用处方抗菌剂的耐药性的发展,世界各地的医疗系统承受了巨大的经济负担。因此,需要预防和治疗UTI的新颖方法。尽管UPEC可能含有大量毒力因子,但I型菌毛和P菌毛是研究最多的两种粘附性细胞器,因为在尿道中附着于宿主细胞是感染的关键步骤。竞争性结合至位于菌毛细胞器顶部的UPEC表面粘附素的受体类似物的设计,导致了抗粘连药物的开发,这种抗粘连药物日益被认为是抗生素治疗UTI的重要和有希望的替代方法

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号